Literature DB >> 15133224

Structure-activity relationships of 2-aminothiazole derivatives as inducible nitric oxide synthase inhibitor.

Shigeo Ueda1, Hideo Terauchi, Motoji Kawasaki, Akihiro Yano, Motoharu Ido.   

Abstract

Nitric oxide synthase (NOS) has been divided into two major sub-enzymes, i.e. inducible NOS (iNOS) and constitutive NOS (cNOS). Although nitric oxide (NO) plays an important role as host defense mediator, excessive production of NO by iNOS has been involved in the pathology of many inflammatory diseases. Recently, we reported that the 2-imino-1,3-oxazolidine (1a) weakly inhibits iNOS and that introduction of an alkyl moiety on the oxazolidine ring of 1a enhances the inhibitory activity and selectivity for iNOS. In our search for better iNOS inhibitors, we focused our efforts on the 2-aminothiazole scaffold 3 as it possesses a ring similar to that of 1a. In this study, we evaluated the inhibitory activity of a series of 2-aminothiazole derivatives against both iNOS and neuronal NOS (nNOS). Our results show that introduction of appropriately-sized substituents at the 4- and 5-position of the 2-aminothiazole ring improves the inhibitory activity and selectivity for iNOS. We also found that the selectivity of 5a [5-(1-methyl)ethyl-4-methylthiazol-2-ylamine] and 5b [5-(1,1-dimethyl)ethyl-4-methylthiazol-2-ylamine] for iNOS was similar to that of oxazolidine derivative 1b (4-methyl-5-propyl-2-imino-1,3-oxazolidine) and much higher than that of L-NAME. However, we could not enhance the inhibitory activity against iNOS by introducing an alkyl substituent into the 2-aminothiazole ring as we could in the case of oxazolidine one. On the other hand, introduction of bulky or hydrophilic substituent at any position of the 2-aminothiazole ring remarkably decreased or even abolished the inhibitory activity against NOS.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15133224     DOI: 10.1248/cpb.52.634

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Antiglioma Activity of Aryl and Amido-Aryl Acetamidine Derivatives Targeting iNOS: Synthesis and Biological Evaluation.

Authors:  Cristina Maccallini; Fabio Arias; Marialucia Gallorini; Pasquale Amoia; Alessandra Ammazzalorso; Barbara De Filippis; Marialuigia Fantacuzzi; Letizia Giampietro; Amelia Cataldi; María Encarnación Camacho; Rosa Amoroso
Journal:  ACS Med Chem Lett       Date:  2020-06-19       Impact factor: 4.345

2.  Design of benzene-1,2-diamines as selective inducible nitric oxide synthase inhibitors: a combined de novo design and docking analysis.

Authors:  Sandrea M Francis; Amit Mittal; Manishika Sharma; Prasad V Bharatam
Journal:  J Mol Model       Date:  2008-01-12       Impact factor: 1.810

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.